Moderna To Make Profit On Vaccine Development, Testing And Patent – OpEd

Moderna, a relatively new biotech company, has generally been seen as the leading U.S. contender to develop a coronavirus vaccine, although it trails several Chinese companies. Whether or not its vaccine pans out, it should certainly get an award for milking the government.

It was the big winner in initial contracts, getting...